BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21267559)

  • 1. Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis.
    Falk RH; Dorbala S
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):467-9. PubMed ID: 21267559
    [No Abstract]   [Full Text] [Related]  

  • 2. A sparkling case of familial, cardiac-specific amyloidosis.
    Villines TC; Atwood JE
    Clin Cardiol; 2006 Feb; 29(2):89. PubMed ID: 16506646
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear imaging in cardiac amyloidosis.
    Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of positron emission tomography in cardiac amyloidosis.
    Saeed S; Saad JM; Ahmed AI; Han Y; Al-Mallah MH
    Heart Fail Rev; 2022 Sep; 27(5):1531-1541. PubMed ID: 34743267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging in cardiac amyloidosis.
    Pennell DJ; Maceira AM
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1378-80. PubMed ID: 20083071
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac amyloidosis. Two main subtypes and diagnosis by Nuclear Medicine: SPET tracer revival.
    Valsamaki PN; Zissimopoulos A
    Hell J Nucl Med; 2019; 22(3):161-164. PubMed ID: 31587024
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue Doppler imaging and contrast-enhanced cardiac magnetic resonance in primary cardiac amyloidosis.
    Smedema JP; James R
    Eur J Echocardiogr; 2009 Dec; 10(8):984-6. PubMed ID: 19749196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
    Eriksson P; Backman C; Bjerle P; Eriksson A; Holm S; Olofsson BO
    Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echography and scintigraphy using technetium 99m pyrophosphate in the diagnosis of cardiac amyloidosis].
    Guy JM; Lamaud M; Segura C; Berthaud T; Duranton B; Verneyre H
    Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):215-8. PubMed ID: 2544133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Your choices in heart scans.
    Park A; Scalet C
    Time; 2005 Sep; 166(10):65-6. PubMed ID: 16158831
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue Doppler features of cardiac amyloidosis.
    Elliott PM; Mahon NG; Matsumura Y; Hawkins PN; Gillmore JD; McKenna WJ
    Clin Cardiol; 2000 Sep; 23(9):701. PubMed ID: 11016022
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac amyloidosis diagnosed incidentally by bone scintigraphy.
    Wechalekar K; Ng FS; Poole-Wilson PA; Duncan A; Nutting C; Naidoo VV; Underwood SR
    J Nucl Cardiol; 2007; 14(5):750-3. PubMed ID: 17826329
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement.
    Ak I; Vardareli E; Erdinĉ O; Kasapoğlu E; Ata N
    Clin Nucl Med; 2000 Oct; 25(10):826-7. PubMed ID: 11043729
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts.
    Oda S; Kidoh M; Nagayama Y; Takashio S; Usuku H; Ueda M; Yamashita T; Ando Y; Tsujita K; Yamashita Y
    Radiographics; 2020; 40(4):961-981. PubMed ID: 32442047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis.
    Rapezzi C; Guidalotti P; Salvi F; Riva L; Perugini E
    J Am Coll Cardiol; 2008 Apr; 51(15):1509-10; author reply 1510. PubMed ID: 18402909
    [No Abstract]   [Full Text] [Related]  

  • 18. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
    Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
    Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac denervation in amyloid polyneuropathy.
    Nakata T; Shimamoto K
    Lancet; 2003 Apr; 361(9364):1181. PubMed ID: 12686040
    [No Abstract]   [Full Text] [Related]  

  • 20. Does hybrid diagnostic imaging in cardiology have the same significance as in oncology?
    Georgoulias P; Tsougos I; Valotassiou V; Demakopoulos N
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):979-81. PubMed ID: 21336693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.